Antiflex and Burosumab-twza Subcutaneous
Determining the interaction of Antiflex and Burosumab-twza Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Antiflex (Injection)
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antiflex-Buspar
- Antiflex-Buspar Dividose
- Antiflex-Buspirone
- Antiflex-Buspirone Hydrochloride
- Antiflex-Busulfan
- Antiflex-Busulfan Concentrate Injection
- Burosumab-twza Subcutaneous-Antifungal
- Burosumab-twza Subcutaneous-Antihemophilic and von Willebrand factor complex
- Burosumab-twza Subcutaneous-Antihemophilic Factor (Recombinant [Fc Fusion Protein])
- Burosumab-twza Subcutaneous-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Burosumab-twza Subcutaneous-Antihemophilic Factor (Recombinant [Pegylated])
- Burosumab-twza Subcutaneous-Antihemophilic Factor (Recombinant [Pegylated]) Injection